Epigenetic Alterations in Bone and Soft Tissue Tumors.

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Human malignancies stem from heritable alterations, including DNA sequence changes and epigenetic modifications affecting gene expression.
• High-throughput sequencing reveals mutations in epigenetic regulatory complexes are crucial in cancer development.
• Epigenetic regulators control chromatin accessibility and gene transcription, and their dysfunction can activate oncogenes or silence tumor suppressors.

Purpose of the Study:

• To review recent advances in understanding the molecular pathogenesis of specific human malignancies.
• To focus on tumors where alterations in Polycomb complexes, SWI/SNF remodelers, and histones are central to disease development.
• To highlight the link between molecular pathogenesis and novel diagnostic markers.

Main Methods:

• Review of recent scientific literature on epigenetic alterations in cancer.
• Analysis of high-throughput sequencing data implicating epigenetic regulators in oncogenesis.
• Focus on molecular mechanisms in mesenchymal and neuroectodermal tumors.

Main Results:

• Epigenetic regulators, particularly Polycomb and SWI/SNF complexes and histones, are frequently altered in human cancers.
• These alterations play a critical role in the pathogenesis of mesenchymal and neuroectodermal tumors.
• Understanding these molecular mechanisms facilitates the development of new diagnostic markers.

Conclusions:

• Epigenetic dysregulation is a fundamental mechanism in human tumorigenesis.
• Targeting epigenetic pathways presents potential therapeutic strategies.
• Advances in molecular pathology are improving cancer diagnosis and classification.